Mitochondrial Function and Pathology
Mitochondrial Function and Pathology is a research topic within Molecular Biology. Science Explorer counts 84k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the dynamics of mitochondria, the production and regulation of reactive oxygen species (ROS), and their implications in various biological processes such as aging, neurodegenerative diseases, and metabolic regulation. The papers cover topics including mitochondrial fusion and fission, oxidative stress, mitochondrial dysfunction, and the role of mitochondria in cell death.
- Mitochondria
- Reactive Oxygen Species
- Oxidative Stress
- Mitochondrial Dysfunction
- Cell Death
- Mitochondrial Fusion
- Mitochondrial Fission
- Aging
- Neurodegenerative Diseases
- Metabolic Regulation
- Research works
- 84k fractional, since 1950
- In the world top 10%
- 8.3k per year above
- Top-10% rate
- 9.9% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +8% the tick is no change
- Largest producer
United States
34% of the 10 largest, 2022-now
Which countries lead Mitochondrial Function and Pathology research?
By volume, the United States and China publish the most (3.3k and 2.8k works in 2022-now).
By volume, 2022-now
- 1
United States 3.3k works
- 2
China 2.8k works
- 3
India 552 works
- 4
Germany 548 works
- 5
Japan 498 works
- 6
United Kingdom 498 works
- 7
Italy 480 works
- 8
France 359 works
- 9
Canada 334 works
- 10
Russia 300 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Mitochondrial Function and Pathology research?
By volume in 2022-now, Harvard University publishes the most Mitochondrial Function and Pathology research, followed by Russian Academy of Sciences and Centre National de la Recherche Scientifique.
By volume, 2022-now
- 1
Harvard University
United States 110 works
- 2
Russian Academy of Sciences
Russia 109 works
- 3
Centre National de la Recherche Scientifique
France 104 works
- 4
National Institutes of Health
United States 91 works
- 5
Chinese Academy of Sciences
China 75 works
- 6
Zhejiang University
China 68 works
- 7
Inserm
France 66 works
- 8
Shanghai Jiao Tong University
China 64 works
- 9
University College London
United Kingdom 63 works
- 10
Johns Hopkins University
United States 58 works
Who are the leading researchers in Mitochondrial Function and Pathology?
The most-cited researchers publishing on Mitochondrial Function and Pathology include Eric S. Lander, George Davey Smith and Richard M. Durbin.
- 1
Eric S. Lander
United States 524k citations
- 2
George Davey Smith
United Kingdom 435k citations
- 3
Richard M. Durbin
United Kingdom 410k citations
- 4
Mark J. Daly
United States 403k citations
- 5
Stacey L. Gabriel
United States 402k citations
- 6
Peer Bork
Germany 396k citations
- 7
Guido Kroemer
France 386k citations
- 8
Bert Vogelstein
United States 373k citations
- 9
Gad A. Getz
United States 364k citations
- 10
Elaine R. Mardis
United States 346k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Mitochondrial Function and Pathology research done?
The largest centres of Mitochondrial Function and Pathology research in 2022-now are Beijing (China), Shanghai (China), Paris (France) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Pushchino, Oklahoma City and Luzhou.
Largest cities, 2022-now
Where it is the local speciality
- PushchinoRU · 24.5 works28×
- Oklahoma CityUS · 23.6 works7.4×
- LuzhouCN · 20.8 works6.7×
Location quotient: how much more of its research is in Mitochondrial Function and Pathology than the world average.
Where is the best place to study Mitochondrial Function and Pathology?
Among universities, judged by research, Harvard University, Wuhan University and University of Cambridge score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Mitochondrial Function and Pathology, country by countryIs Mitochondrial Function and Pathology research growing?
Output in 2022-2025 was 8% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Mitochondrial Function and Pathology.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Mitochondrial Function and Pathology as a percentage of every work published that year, 0.055% in 2024.
Fractional works of Mitochondrial Function and Pathology over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Mitochondrial Function and Pathology. Posts are plain text and can be reported.